Absorb (n = 10) | Synergy (n = 10) | p | |
---|---|---|---|
N (%) | N (%) | ||
ROI length (mm) | 23.28 ± 4.25a | 21.03 ± 6.39 | 0.366 |
Proximal reference lumen area (mm2) | 7.94 ± 2.89 | 11.15 ± 3.57 | 0.053 |
Distal reference lumen area (mm2) | 7.85 ± 2.96 | 9.65 ± 3.22 | 0.209 |
Minimal lumen area (mm2) | 5.07 ± 2.00 | 7.73 ± 2.12 | 0.010 |
Endoluminal neointimal | 17.46 ± 6.91 | 14.42 ± 4.72 | 0.266 |
stent/scaffold volume (mm3) | |||
Abluminal neointimal + stent/scaffold strut volume (mm3) | 44.34 ± 14.27 | 33.57 ± 10.94 | 0.074 |
Abluminal stent area (mm2) | 7.03 ± 2.04 | 9.48 ± 2.47 | 0.027 |
Endoluminal stent area (mm2) | 5.39 ± 1.87 | 8.13 ± 2.19 | 0.008 |
Malapposition volume > 0 mm3 | 2 (20%) | 3 (30%) | 1.000 |
Stent/scaffold with > 30% area stenosis | 3 (30%) | 0 (0%) | 0.211 |
% area stenosis | 18.4 + 15.8 | 7.6 ± 7.5 | 0.067 |
Neointimal thickness (mm) | 0.04 (0.03–0.05)b | 0.05 (0.04–0.06) | 0.385 |
Maximal neointimal thickness (mm) | 0.209 (0.173–0.245) | 0.220 (0.140–0.260) | 0.880 |
Maximal in-stent/scaffold obstruction (%) | 11.5 (10–13) | 11.5 (10–14) | 0.970 |
In-stent/scaffold obstruction (%) | 7.89 (6.84–9.42) | 6.98 (6.26–7.33) | 0.112 |
Neointima | |||
Homogeneous | 6 (60%) | 30 (30%) | |
Heterogeneous | 4 (40%) | 70 (70%) | 0.370 |
Disrupted stent/scaffold | 1 (10%) | 0 | 1.000 |